Infliximab IV Dosing for an 80 kg Patient
Learn how Baysient’s T3 application simplifies Infliximab IV dosing for an 80 kg adult patient. In this video walkthrough, we demonstrate how to input patient-specific details — weight, last dose, dosing interval, and observed trough concentration — to create an individualized dosing regimen.
Key highlights include:
✔ Using T3 to generate a custom dosing nomogram tailored to the patient’s half-life and target trough concentration.
✔ Running simulations to see the impact of different doses (5 mg/kg, 7.5 mg/kg, etc.) and dosing intervals on achieving therapeutic troughs.
✔ Understanding probability charts for anti-drug antibody risk, remission likelihood, and CRP normalization outcomes.
Watch the video to discover how T3 enables precision dosing, helping gastroenterologists improve patient outcomes with data-driven adjustments to standard dosing intervals.